文献速递心力衰竭与心肌病肺血管病与心包/心肌炎

射血分数保留的心力衰竭中肺动脉高压血流动力学标志物与结局的关联

Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
PubMed 文献 · JAMA Cardiol · 2018-01-01

中位随访1578天,PH-HFpEF患者1年死亡率为23.6%、5年死亡率为48.2%,跨肺压力梯度、肺血管阻力和舒张期肺动脉梯度均与死亡和心脏住院相关。

要点

  • PH-HFpEF在右心导管检查人群中常见,占25.8%。
  • PH-HFpEF患者1年死亡率23.6%,5年死亡率48.2%。
  • 跨肺压力梯度、肺血管阻力和舒张期肺动脉梯度可预测死亡和心脏住院。

核心结论

  • 在因有创血流动力学评估转诊的大型队列中,PH-HFpEF常见,跨肺压力梯度、肺血管阻力和舒张期肺动脉梯度均与死亡和心脏住院相关。

主要发现

  • 2587例(25.8%)为PH-HFpEF,1年死亡率为23.6%,5年死亡率为48.2%。
  • 1年心脏住院率为28.1%,5年心脏住院率为47.4%。
  • 跨肺压力梯度>12 mm Hg、肺血管阻力3 Woods单位、舒张期肺动脉梯度≥7 mm Hg的频率分别为12.6%、8.8%、3.5%。

关键数值与推荐

  • PH-HFpEF定义为平均肺动脉压≥25 mm Hg、肺动脉楔压≥15 mm Hg且左心室射血分数≥45%。
  • 肺动脉高压严重程度通过跨肺压力梯度、肺血管阻力和舒张期肺动脉梯度量化。

临床怎么用

  • 对HFpEF患者进行有创血流动力学评估时,应关注跨肺压力梯度、肺血管阻力和舒张期肺动脉梯度以进行风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, yet there are no specific therapies, possibly due to phenotypic heterogeneity. The development of pulmonary hypertension (PH) in patients with HFpEF is considered a high-risk phenotype in need of targeted therapies, but there have been limited hemodynamic and outcomes data. OBJECTIVE: To identify the hemodynamic characteristics and outcomes of PH-HFpEF. DESIGN, SETTING, AND PARTICIPANTS: Cohort study of participants who had a right heart catheterization from January 2005 to September 2012 (median [interquartile range] follow-up time, 1578 [554-2513] days) were analyzed. Hemodynamic catheterization data was linked to the clinical data repository of all inpatient and outpatient encounters across a health system. Single tertiary referral center for heart failure and PH within a large health care network using a common clinical data repository was studied. There were 19 262 procedures in 10 023 participants. EXPOSURES: Participants were classified as having no PH, precapillary PH, or PH in the setting of left heart disease (reduced or preserved ejection fraction). Pulmonary hypertension associated with HFpEF was defined as mean pulmonary artery pressure of 25 mm Hg or more, pulmonary artery wedge pressure of 15 mm Hg or more, and left ventricular ejection fraction of 45% or more. Pulmonary hypertension severity was quantified by the hemodynamic parameters transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient. MAIN OUTCOMES AND MEASURES: The primary outcome was time to all-cause mortality. Secondary outcomes were time to acute hospitalization and cardiovascular hospitalization. RESULTS: The mean (SD) of all study individuals was 65 (38) years. Of 10 023 individuals, 2587 (25.8%) had PH-HFpEF. Mortality was 23.6% at 1 year and 48.2% at 5 years. Cardiac hospitalizations occurred in 28.1% at 1 year and 47.4% at 5 years. The frequency of precapillary PH using clinically defined cut-offs for transpulmonary gradient (>12 mm Hg), pulmonary vascular resistance (3 Woods units), and diastolic pulmonary gradient (≥7 mm Hg) were 12.6%, 8.8%, and 3.5%, respectively. Transpulmonary gradient, pulmonary vascular resistance, and diastolic pressure gradient were predictive of mortality and cardiac hospitalizations. CONCLUSIONS AND RELEVANCE: In a large cohort referred for invasive hemodynamic assessment, PH-HFpEF was common. Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are all associated with mortality and cardiac hospitalizations.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Vanderpool RR, Saul M, Nouraie M, et al. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2018. PMID: 29541759. doi:10.1001/jamacardio.2018.0128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。